The famous tale of the Trojan Horse is one where strategic planning beat out the power of the sword. The Greek’s victory over the Trojans demonstrates how knowing your enemy well is key to securing the most effective victory.
One of the reasons why chemotherapy treatments are difficult is because cancer cells are equipped with sophisticated defense mechanisms on their membranes that resist contact from anticancer drugs.
Fusión de campanillas en el sector sanitario. El fondo de capital riesgo CVC se ha hecho con el control de Quirón Grupo Hospitalario tras adquirir el 60% del capital en manos de la firma de inversión Doughty Hanson, según confirmó el grupo zaragozano ayer lunes a su equipo directivo.
La compañía estadounidense Medtronic ha acordado la adquisición de la irlandesa Covidien por 42.900 millones de dólares (31.665 millones de euros) para crear un gigante mundial en el suministro de material médico.
Medtronic pagará un total de 93,22 dólars en efectivo y acciones por cada título de Covidien, cifra que supone una prima del 29% sobre el cierre de las acciones de Covidien el pasado viernes.
La nueva compañía resultante de la operación, que se denominará Medtronic, tendrá su sede en Irlanda por motivos fiscales.
After all the angst generated by the Affordable Care Act, and all the punditry, noise, and debate that accompanied its rollout, you might conclude that there are no practical solutions to our healthcare challenges. But, of course, there are new answers and solutions and new, creative approaches to solving healthcare problems. You just have to look at innovative, private sector enterprises. And if you do, you might find one of the more innovative answers to eldercare right there in your old-fashioned television set. Just ask Kian Saneii, CEO of Independa.
Chrono Therapeutics‘ wearable, called SmartStop, injects a tiny bit of nicotine into the wearer’s bloodstream at timed intervals.
In this way it’s similar to the patch, but SmartStop gives the wearer some control over when that happens. Timing the introduction of the nicotine can help the user deal with cravings, the company says.
Ashkelon’s Barzilai Hospital, in southern Israel, is one of the first in the world to use the Biotronik Etrinsa HF-T, a new “connected” pacemaker that allows physicians to gather potentially lifesaving data about a patient’s cardiac condition anytime and anywhere. The device is one of the world’s first to use a cellular phone network to communicate with a server and upload data about pacemaker behavior and impact, sending text messages to doctors for analysis and interpretation.
Doctors and patients are starting to use digital tools to manage healthcare more efficiently, but the current environment remains disjointed. Looking toward the future, however, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones. And in the process, they will help create a more connected digital healthcare ecosystem that has benefits for everyone. Here’s what it might look like.
Medicare rolls are swelling and the Affordable Care Act is bringing more people under the umbrella of insurance coverage. As a result, medical groups and health plans have an ever-more pressing need to predict the costs of care.
San Mateo, Calif.-based Apixio wants to fill that need by crunching a lot of existing clinical data, providing healthcare organizations with the intel they need to accurately estimate patient risk. That enables providers to more accurately (and profitably) bill for their services.
Apixio says it uses natural language processing and machine learning to make sense of a mountain of unstructured data.
